People can only gather inside with their households and can only leave home for essential reasons.
Many outdoor recreation venues can now reopen under the order and Ontario s outdoor distanced gathering limit has risen to five people, including people from different households.
Most non-essential businesses can only offer curbside pickup. Access to malls is restricted and big-box stores can only sell essential items.
Gyms and personal care services are closed, while restaurants are only available for takeout and delivery.
A staff member helps a child try on a PFD as people line up to rent canoes, kayaks and paddle boats at the Dow s Lake Marina in Ottawa, on Sunday, May 30, 2021.(Justin Tang/Canadian Press)
Published Thursday, May 27, 2021 5:44AM EDT HALIFAX - Nova Scotia s growing success in getting its population vaccinated against COVID-19 has created a roadblock for a clinical trial of a Canadian-made vaccine. The Canadian Centre for Vaccinology at Dalhousie University is trying to complete a Phase 1 trial for a COVID-19 vaccine developed by Edmonton-based Entos Pharmaceuticals Inc. but says it s difficult to find volunteers as more people get shots. The centre s director, Dr. Scott Halperin, says the search is on for about a dozen people aged between 18 and 55 who haven t been vaccinated yet and who haven t been exposed to the virus to complete the initial phase of the trial.
A Canadian-made COVID-19 vaccine undergoing clinical trials in Halifax is having trouble recruiting enough participants as vaccination rates increase in Nova Scotia.
Keith Doucette
Dr. John Lewis, CEO of Edmonton-based Entos Pharmaceuticals Inc., is shown in a handout photo. Clinical trials for a Canadian-made COVID-19 vaccine have hit a roadblock with the success of increasing vaccination rates in Nova Scotia.THE CANADIAN PRESS/HO May 27, 2021 - 1:00 AM
HALIFAX - A Canadian-made COVID-19 vaccine undergoing clinical trials in Halifax is having trouble recruiting enough participants as vaccination rates increase in Nova Scotia.
The Canadian Centre for Vaccinology at Dalhousie University is trying to complete the second stage of the Phase 1 trial for a vaccine developed by Edmonton-based Entos Pharmaceuticals but says it s hard to find volunteers as more people get shots.